checkAd

     209  0 Kommentare Jaguar Health Reports Approval of All Proposals at June 2024 Annual Meeting of Stockholders

    Jaguar to report pivotal phase 3 OnTarget trial results for its cancer supportive care drug crofelemer on or before July 23, 2024Investor webcast on or before July 23 will include updates on Jaguar's cancer supportive care portfolio, including …

    Jaguar to report pivotal phase 3 OnTarget trial results for its cancer supportive care drug crofelemer on or before July 23, 2024

    Investor webcast on or before July 23 will include updates on Jaguar's cancer supportive care portfolio, including participation from Jaguar scientific team, patient advocates, and leading oncology experts on cancer therapy-related diarrhea and oral mucositis

    In honor of World Rainforest Day (June 22), Jaguar is proud to share RealPharma podcast interview with ethnobotanist Dr. Steven King

    SAN FRANCISCO, CA / ACCESSWIRE / June 21, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced the voting results of the Company's Annual Meeting of Stockholders held June 21, 2024 (the "Annual Meeting").

    Five proposals were submitted to and approved by the stockholders of the Company at the Annual Meeting. The proposals are described in detail in the Company's definitive proxy statement on Schedule 14A relating to the Annual Meeting on May 21, 2024 and supplemental information filed with the Securities and Exchange Commission. Stockholders may obtain a free copy of the proxy statement and other documents filed by Jaguar with the SEC at http://www.sec.gov. The proxy statement is also available on the Company's corporate website.

    "In honor of World Rainforest Day (June 22), we are proud to share the link to RealPharma's recent podcast interview with ethnobotanist Steven King, PhD, Jaguar's Chief Sustainable Supply, Ethnobotanical Research, and IP Officer," said Lisa Conte, the Company's founder, president and CEO. "The RealPharma podcast series is hosted by Dr. Na-Ri Oh and Ian Wendt, Jaguar's Chief Commercial Officer. In the interview, Dr. King shares incredible stories from his journey - like living with indigenous communities in the Amazon and learning about their medicinal uses of plants. He also discusses the powerful impact these natural resources can have on global health, all while preserving the cultures that discovered them. It's a testament to how ancient wisdom and cutting-edge science can work hand-in-hand. The podcast episode can be accessed at this link: From the Forest to your Pharmacy: Dr. Steven King's Ethnobotanical Journey."

    Seite 1 von 2



    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We’re a newswire service standout and fast becoming an industry disruptor. We provide regional, national and global news to thousands of clients around the world. We’re also leading the way in social engagement, targeting and analytics.
    Mehr anzeigen
    Verfasst von Accesswire
    Jaguar Health Reports Approval of All Proposals at June 2024 Annual Meeting of Stockholders Jaguar to report pivotal phase 3 OnTarget trial results for its cancer supportive care drug crofelemer on or before July 23, 2024Investor webcast on or before July 23 will include updates on Jaguar's cancer supportive care portfolio, including …